This finding does not seem to be a spurious association, as hydroxychloroquine has been associated with a reduced risk of diabetes and metabolic syndrome in patients with rheumatoid arthritis24,25 and SLE10,26,27, most probably due to an effect on insulin sensitivity, and increased beta cell function, as well as anti-inflammatory and anti-oxidant mechanisms28. This evidence concerns the gene INS and metabolic syndrome.